Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$1.6 - $3.99 $31,360 - $78,204
-19,600 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$2.8 - $3.96 $1.29 Million - $1.82 Million
-460,300 Reduced 95.92%
19,600 $70,000
Q4 2021

Feb 10, 2022

SELL
$3.63 - $6.13 $148,557 - $250,870
-40,925 Reduced 7.86%
479,900 $1.88 Million
Q2 2021

Jul 28, 2021

SELL
$4.35 - $6.35 $87,000 - $127,000
-20,000 Reduced 3.7%
520,825 $3.21 Million
Q1 2021

Apr 28, 2021

BUY
$3.94 - $7.09 $679,354 - $1.22 Million
172,425 Added 46.8%
540,825 $2.45 Million
Q4 2020

Feb 09, 2021

BUY
$5.45 - $8.65 $196,063 - $311,183
35,975 Added 10.82%
368,400 $2.21 Million
Q3 2020

Oct 28, 2020

BUY
$4.34 - $11.43 $339,205 - $893,345
78,158 Added 30.74%
332,425 $2.47 Million
Q1 2020

Apr 29, 2020

BUY
$1.24 - $4.35 $38,048 - $133,475
30,684 Added 13.72%
254,267 $646,000
Q4 2019

Feb 03, 2020

SELL
$2.3 - $5.12 $20,010 - $44,544
-8,700 Reduced 3.75%
223,583 $778,000
Q3 2019

Oct 23, 2019

SELL
$4.63 - $12.15 $303,343 - $796,031
-65,517 Reduced 22.0%
232,283 $1.08 Million
Q2 2019

Aug 09, 2019

SELL
$11.49 - $14.17 $383,191 - $472,569
-33,350 Reduced 10.07%
297,800 $3.67 Million
Q1 2019

Apr 22, 2019

BUY
$8.47 - $14.36 $53,784 - $91,186
6,350 Added 1.96%
331,150 $4.4 Million
Q4 2018

Feb 11, 2019

BUY
$7.18 - $8.83 $763,234 - $938,629
106,300 Added 48.65%
324,800 $2.8 Million
Q3 2018

Oct 22, 2018

BUY
$5.92 - $8.35 $293,040 - $413,325
49,500 Added 29.29%
218,500 $1.64 Million
Q2 2018

Aug 02, 2018

BUY
$4.86 - $6.24 $74,115 - $95,160
15,250 Added 9.92%
169,000 $1.01 Million
Q1 2018

Apr 23, 2018

BUY
$5.75 - $7.97 $121,325 - $168,167
21,100 Added 15.91%
153,750 $898,000
Q4 2017

Jan 26, 2018

BUY
$4.46 - $6.45 $591,619 - $855,592
132,650
132,650 $781,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.